Eisai

Anonymous board for Eisai.
Post thread


Amyloid Hypothesis in Doubt as Newly Approved Drugs Hit Hurdles - BioSpace
Replies
21
Views
2K
anonymous
FiercePharma: Neurologists paint bleak Leqembi launch picture as Alzheimer's drug trips up on a host of challenges
Replies
4
Views
659
anonymous
Portland Oncology Opening be warned
Replies
3
Views
611
anonymous
Oncology stooge J Stott we inherited him at BI
Replies
4
Views
607
anonymous
lunch sign in sheets
Replies
14
Views
14K
anonymous
Eisai Cuts Leqembi Sales Forecast by 25%, BioArctic Royalties Impacted | BIOA Stock News
Replies
8
Views
1K
anonymous
Happy Pearl Harbor Day
Replies
2
Views
325
anonymous
Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome | Fierce Pharma
Replies
2
Views
356
anonymous
Eisai dials back forecasts for Alzheimer's drug Leqembi | pharmaphorum
Replies
5
Views
766
anonymous
EXEL Earnings Call
Replies
9
Views
802
anonymous
FierceBiotech: Eisai, Lilly Alzheimer’s trials withheld brain injury risk: NYT
Replies
11
Views
874
anonymous
You do not pay well in oncology.
Replies
8
Views
1K
anonymous
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials - The New York Times
Replies
5
Views
605
anonymous
Australia Is Latest Country to Say 'No' to Leqembi | Being Patient
Replies
1
Views
246
anonymous
Leqembi and the Aussies
Replies
2
Views
341
anonymous
FiercePharma: Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Replies
1
Views
377
anonymous
Happy at Eisai with neurology position
Replies
39
Views
7K
anonymous
What's the scoop on Bill McLean?
Replies
43
Views
17K
anonymous
Debate rages over Alzheimer’s drug lecanemab as UK limits approval
Replies
2
Views
386
anonymous
Endpoints: Eisai says Alzheimer's drug keeps working after three years. But weaknesses in study raise questions
Replies
8
Views
1K
anonymous
Top Bottom
Back
Post thread